leisure time -WSS

leisure time

author：leisure time 2025-09-06 02:03:20 - browse：94

Perrigo Opill press photo – pharma coverage from STAT — Opill, the first over-the-counter birth control pill, is on its way to U.S. stores. Perrigo via AP

WASHINGTON — The first over-the-counter birth control pill will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin.

Manufacturer Perrigo said Monday it has begun shipping the medication, Opill, to major retailers and pharmacies. A one-month supply will cost about $20 and a three-month supply will cost around $50, according to the company’s suggested retail price. It will also be sold online.

The launch has been closely watched since last July, when the Food and Drug Administration said the once-a-day Opill could be sold without a prescription. Ireland-based Perrigo noted there will be no age restrictions on sales, similar to other over-the-counter medications.

Opill is an older class of contraceptive, sometimes called minipills, that contain a single synthetic hormone, progestin, and generally carry fewer side effects than more popular combination estrogen and progestin pills.

Newsletters

Sign up for Morning Rounds

Understand how science, health policy, and medicine shape the world every day

Please enter a valid email address. Privacy Policy

The launch gives U.S. women another birth control option amid the legal and political battles over reproductive health, including the reversal of Roe v. Wade, which has upended abortion access across the U.S. Opill’s approval is unrelated to the ongoing court battles over the abortion pill mifepristone. And anti-abortion groups have generally emphasized that they do not oppose contraceptives to prevent pregnancies.

Birth control pills are available without a prescription across much of South America, Asia, and Africa.

The drug’s approval came despite some concerns by FDA scientists about the company’s results, including whether women with certain medical conditions would understand that they shouldn’t take the drug.

Dr. Verda Hicks, president of the American College of Obstetricians and Gynecologists, in a statement, said studies have shown that patients, including adolescents, can effectively screen themselves to use the pills.

— Matthew Perrone

Previous article： In Memoriam: Notable people who died in 2023
Next article： Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

hotspot

WSS

Cybersecurity threat forces Lurie Children's to take systems offline

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Following judge's order, DOJ releases slightly less

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

Adele warns fans about throwing things at performers onstage

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Wikipedia

leisure time

Sign up for Morning Rounds

Wikipedia

How one medical school became remarkably diverse

Accuser says Kevin Spacey grope wasn't a caress: ‘It was like a cobra ... angry’

As demand for Covid shots wanes, Moderna seeks its next success

Israel withdraws forces after 2

Bright Health sells Medicare Advantage business to Molina

ARCH Venture Partners is raising $3 billion for a life sciences fund

Alkermes shareholders re

Do digital therapeutics have a future in medicine?

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

5 shark bites reported on Long Island as officials deploy surveillance drones

hotspot

Pope Francis asks Church to identify 21st

Time to name cancers by genetics, not organ of origin, expert says

Medicare drug price negotiation’s day in court

What we need to know about Arena Bioworks

Medicare drug price negotiation’s day in court

A $475,000 price tag for a new cancer drug: crazy or meh?

hotspot

entertainment

hotspot

knowledge